MMP1 Gene Epidermolysis bullosa dystrophica autosomal recessive modifier of Genetic Test
Test Name: MMP1 Gene Epidermolysis bullosa dystrophica autosomal recessive modifier of Genetic Test
Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Osteology Dermatology Immunology Disorders
- Doctor: Dermatologist
- Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for MMP1 Gene Epidermolysis bullosa dystrophica, autosomal recessive, modifier of NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MMP1 Gene Epidermolysis bullosa dystrophica, autosomal recessive, modifier of NGS Genetic DNA Test gene MMP1.
Test Details:
The MMP1 gene is not directly associated with Epidermolysis bullosa dystrophica, which is a genetic disorder characterized by skin blistering and fragility. However, it is possible that the MMP1 gene may act as a modifier of the disease. Modifier genes are genes that can influence the severity or progression of a particular genetic disorder when present alongside the primary disease-causing gene mutation. In the case of Epidermolysis bullosa dystrophica, the primary gene mutations are typically found in the COL7A1 gene.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or the entire genome. It can help identify mutations in the primary disease-causing gene as well as potential modifier genes like MMP1. By analyzing the MMP1 gene alongside the primary disease-causing gene, NGS genetic testing may provide a more comprehensive understanding of the genetic factors contributing to the development and progression of Epidermolysis bullosa dystrophica. This information can be valuable for prognosis, treatment planning, and genetic counseling.
| Test Name | MMP1 Gene Epidermolysis bullosa dystrophica autosomal recessive modifier of Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MMP1 Gene Epidermolysis bullosa dystrophica, autosomal recessive, modifier of NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MMP1 Gene Epidermolysis bullosa dystrophica, autosomal recessive, modifier of NGS Genetic DNA Test gene MMP1 |
| Test Details |
The MMP1 gene is not directly associated with Epidermolysis bullosa dystrophica, which is a genetic disorder characterized by skin blistering and fragility. However, it is possible that the MMP1 gene may act as a modifier of the disease. Modifier genes are genes that can influence the severity or progression of a particular genetic disorder when present alongside the primary disease-causing gene mutation. In the case of Epidermolysis bullosa dystrophica, the primary gene mutations are typically found in the COL7A1 gene. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or the entire genome. It can help identify mutations in the primary disease-causing gene as well as potential modifier genes like MMP1. By analyzing the MMP1 gene alongside the primary disease-causing gene, NGS genetic testing may provide a more comprehensive understanding of the genetic factors contributing to the development and progression of Epidermolysis bullosa dystrophica. This information can be valuable for prognosis, treatment planning, and genetic counseling. |

